D-1066-2019 Class II Terminated
FDA drug recall D-1066-2019 was initiated by Ascend Laboratories LLC on Feb 22, 2019 and is designated Class II. Reason for recall: Failed Dissolution Specifications: High Out-of-Specification dissolution results were observed during stability testing. The recall status is terminated (terminated Mar 18, 2020). Affected quantity: 3,072 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Mar 13, 2019
- Initiation Date
- Feb 22, 2019
- Termination Date
- Mar 18, 2020
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 3,072 bottles
Product description
Tamsulosin Hydrochloride Capsules, USP, 0.4 mg, 500-count bottles, Rx Only, Manufactured by: Alkem Laboratories Ltd., Mumbai - 400 013, INDIA; Distributed by Ascend Laboratories, LLC, Parsippany, NJ 07054, NDC 67877-450-05.
Reason for recall
Failed Dissolution Specifications: High Out-of-Specification dissolution results were observed during stability testing.
Distribution pattern
Nationwide in the USA and Puerto Rico.
Code information
Lot #: 8144652, Exp Jul 2020
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-1066-2019
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026